PTGER4 Knockout RT-4 Cell Line
Cat.No.:
EDC07640
Species:
Human
Cell Name:
RT-4
Gene:
PTGER4
Gene ID:
5734
Size:
1×10⁶cells
PTGER4 Knockout RT4 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07640 |
|---|---|
| Product Name | PTGER4 Knockout RT4 Cell Line |
| Species | Human |
| Cell Line | RT-4 |
| Cellosaurus ID | CVCL_0036 |
| Gene ID | |
| Cell Line Synonyms | RT4, RT4P |
| Gene | PTGER4 |
| Summary |
The protein encoded by this gene is a member of the G-protein coupled receptor family. This protein is one of four receptors identified for prostaglandin E2 (PGE2). This receptor can activate T-cell factor signaling. It has been shown to mediate PGE2 induced expression of early growth response 1 (EGR1), regulate the level and stability of cyclooxygenase-2 mRNA, and lead to the phosphorylation of glycogen synthase kinase-3. Knockout studies in mice suggest that this receptor may be involved in the neonatal adaptation of circulatory system, osteoporosis, as well as initiation of skin immune responses. [provided by RefSeq, Jul 2008]
|
| Digestion Time | 6 min |
| Associated Diseases | Bladder Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | McCOY's5A+10% FBS |
| Freezing Medium | 92% complete culture medium+8% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: RT-4 | STR Info (Cell bank) Cell Line: RT-4 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 18 | 19 | 18 | 19 |
| D3S1358 | 15 | 15 | ||
| D5S818 | 11 | 12 | 11 | 12 |
| D7S820 | 9 | 12 | 9 | 12 |
| D8S1179 | 13 | 15 | 13 | 15 |
| D13S317 | 8 | 8 | ||
| D16S539 | 9 | 9 | ||
| D18S51 | 15 | 17 | 15 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 30 | 32.2 | 30 | 32.2 |
| FGA | 22 | 24 | 22 | 24 |
| Penta D | 12 | 13 | 12 | 13 |
| Penta E | 7 | 10 | 7 | 10 |
| TH01 | 9 | 9.3 | 9 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 17 | 14 | 17 |
| D6S1043 | 13 | 19 | ||
| D12S391 | 20 | 22 | ||
| D2S441 | 10 | 13 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PTGER4 function, PTGER4 Knockout RT-4 Cell Line or PTGER4 overexpression RT-4 Cell Line?
The choice depends on whether you are studying PTGER4 (EP4)'s role as the principal Gs-coupled PGE2 receptor or its functions in bladder cancer biology and inflammation. The Knockout line is the standard tool for asking whether EP4 is required for PGE2-induced cAMP elevation and downstream PKA signaling — EP4 has the lowest Km for PGE2 among the four EP receptors and dominates PGE2 responses in many contexts. Overexpression is useful for studying EP4 in cancer contexts where it is upregulated.
For bladder cancer research, the EDITGENE EP4 Knockout in RT-4 is highly relevant — RT-4 is a well-differentiated urothelial papilloma cell line, and EP4 has been implicated in bladder cancer progression, invasion, and immune evasion. Rescue with wild-type or signaling-deficient EP4 enables structure-function studies. The knockout is a critical specificity control for EP4 antagonists (grapiprant, ONO-AE3-208) in oncology and inflammation drug development.
What are the application scenarios for this model?
Primary applications:
• PGE2-cAMP signaling: cAMP measurement following PGE2 stimulation to quantify EP4-dependent Gs signaling.
• Bladder cancer biology: proliferation, invasion, and migration assays in RT-4 to assess EP4's contribution to urothelial cancer phenotypes.
• Anti-EP4 specificity: critical genetic control for grapiprant, ONO-AE3-208, and other EP4 antagonists in cancer and inflammation drug development.
• EP receptor selectivity: comparison with other EP receptor knockouts for EP4-specific PGE2 response characterization.
EDITGENE recommends this model for researchers investigating PGE2-EP4 signaling, bladder cancer biology, and EP4-targeted therapeutic development.
Is this PTGER4 Knockout RT-4 Cell Line compatible with overexpression rescue experiments?
Yes. EP4 rescue experiments are well-established for GPCR pharmacology research:
• Construct design: use a codon-modified PTGER4 sequence with a small intracellular C-terminal tag (FLAG, HA). EP4 is a seven-transmembrane GPCR — N-terminal tags after the signal peptide are tolerated.
• Signaling-deficient rescue: DRY motif mutations or other intracellular loop mutations separate ligand binding from intracellular signaling.
• EP4-selective response: rescue with wild-type EP4 restores PGE2-induced cAMP elevation distinguishable from EP2 (also Gs-coupled but lower affinity).
• Functional readout: rescue should restore PGE2-induced cAMP signaling and bladder cancer-relevant phenotypes.
RT-4 is a urothelial papilloma cell line — transduction with lentivirus is supported at standard efficiency.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download